Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 364 entries
Sorted by: Best Match Show Resources per page
Non-contiguous finished genome sequence and description of Anaerococcus senegalensis sp. nov.

Standards in genomic sciences

Lagier JC, El Karkouri K, Nguyen TT, Armougom F, Raoult D, Fournier PE.
PMID: 22675604
Stand Genomic Sci. 2012 Mar 19;6(1):116-25. doi: 10.4056/sigs.2415480. Epub 2012 Apr 17.

No abstract available.

Cite
Lagier JC, El Karkouri K, Nguyen TT, et al. Non-contiguous finished genome sequence and description of Anaerococcus senegalensis sp. nov. Stand Genomic Sci. 2012;6(1):116-25doi: 10.4056/sigs.2415480.
Lagier, J. C., El Karkouri, K., Nguyen, T. T., Armougom, F., Raoult, D., & Fournier, P. E. (2012). Non-contiguous finished genome sequence and description of Anaerococcus senegalensis sp. nov. Standards in genomic sciences, 6(1), 116-25. https://doi.org/10.4056/sigs.2415480
Lagier, Jean-Christophe, et al. "Non-contiguous finished genome sequence and description of Anaerococcus senegalensis sp. nov." Standards in genomic sciences vol. 6,1 (2012): 116-25. doi: https://doi.org/10.4056/sigs.2415480
Lagier JC, El Karkouri K, Nguyen TT, Armougom F, Raoult D, Fournier PE. Non-contiguous finished genome sequence and description of Anaerococcus senegalensis sp. nov. Stand Genomic Sci. 2012 Mar 19;6(1):116-25. doi: 10.4056/sigs.2415480. Epub 2012 Apr 17. PMID: 22675604; PMCID: PMC3359877.
Copy Download .nbib Format: NLM
Non-contiguous finished genome sequence and description of Brevibacterium senegalense sp. nov.

Standards in genomic sciences

Kokcha S, Ramasamy D, Lagier JC, Robert C, Raoult D, Fournier PE.
PMID: 23408786
Stand Genomic Sci. 2012 Dec 19;7(2):233-45. doi: 10.4056/sigs.3256677. Epub 2012 Dec 10.

Brevibacterium senegalense strain JC43(T) sp. nov. is the type strain of Brevibacterium senegalense sp. nov., a new species within the Brevibacterium genus. This strain, whose genome is described here, was isolated from the fecal flora of a healthy Senegalese...

Cite
Kokcha S, Ramasamy D, Lagier JC, et al. Non-contiguous finished genome sequence and description of Brevibacterium senegalense sp. nov. Stand Genomic Sci. 2012;7(2):233-45doi: 10.4056/sigs.3256677.
Kokcha, S., Ramasamy, D., Lagier, J. C., Robert, C., Raoult, D., & Fournier, P. E. (2012). Non-contiguous finished genome sequence and description of Brevibacterium senegalense sp. nov. Standards in genomic sciences, 7(2), 233-45. https://doi.org/10.4056/sigs.3256677
Kokcha, Sahare, et al. "Non-contiguous finished genome sequence and description of Brevibacterium senegalense sp. nov." Standards in genomic sciences vol. 7,2 (2012): 233-45. doi: https://doi.org/10.4056/sigs.3256677
Kokcha S, Ramasamy D, Lagier JC, Robert C, Raoult D, Fournier PE. Non-contiguous finished genome sequence and description of Brevibacterium senegalense sp. nov. Stand Genomic Sci. 2012 Dec 19;7(2):233-45. doi: 10.4056/sigs.3256677. Epub 2012 Dec 10. PMID: 23408786; PMCID: PMC3569389.
Copy Download .nbib Format: NLM
Iridium(III) soft salts from dinuclear cationic and mononuclear anionic complexes for OLED devices.

Chemical communications (Cambridge, England)

Nasr G, Guerlin A, Dumur F, Beouch L, Dumas E, Clavier G, Miomandre F, Goubard F, Gigmes D, Bertin D, Wantz G, Mayer CR.
PMID: 21892484
Chem Commun (Camb). 2011 Oct 14;47(38):10698-700. doi: 10.1039/c1cc13733f. Epub 2011 Sep 05.

Two iridium(III) soft salts based on ion-paired dinuclear cationic and mononuclear anionic complexes were designed and investigated as phosphorescent emitters for solution processed OLEDs. New dinuclear cationic complexes were prepared with two different bridging ligands, a carbazole and a...

Cite
Nasr G, Guerlin A, Dumur F, et al. Iridium(III) soft salts from dinuclear cationic and mononuclear anionic complexes for OLED devices. Chem Commun (Camb). 2011;47(38):10698-700doi: 10.1039/c1cc13733f.
Nasr, G., Guerlin, A., Dumur, F., Beouch, L., Dumas, E., Clavier, G., Miomandre, F., Goubard, F., Gigmes, D., Bertin, D., Wantz, G., & Mayer, C. R. (2011). Iridium(III) soft salts from dinuclear cationic and mononuclear anionic complexes for OLED devices. Chemical communications (Cambridge, England), 47(38), 10698-700. https://doi.org/10.1039/c1cc13733f
Nasr, Gihane, et al. "Iridium(III) soft salts from dinuclear cationic and mononuclear anionic complexes for OLED devices." Chemical communications (Cambridge, England) vol. 47,38 (2011): 10698-700. doi: https://doi.org/10.1039/c1cc13733f
Nasr G, Guerlin A, Dumur F, Beouch L, Dumas E, Clavier G, Miomandre F, Goubard F, Gigmes D, Bertin D, Wantz G, Mayer CR. Iridium(III) soft salts from dinuclear cationic and mononuclear anionic complexes for OLED devices. Chem Commun (Camb). 2011 Oct 14;47(38):10698-700. doi: 10.1039/c1cc13733f. Epub 2011 Sep 05. PMID: 21892484.
Copy Download .nbib Format: NLM
Assessment of Resisted Trunk Rotation Exercise With and Without .

Journal of chiropractic medicine

Dagher G, Papuga MO.
PMID: 30846917
J Chiropr Med. 2018 Dec;17(4):244-255. doi: 10.1016/j.jcm.2018.07.001. Epub 2019 Jan 20.

OBJECTIVE: The purpose of this study was to assess the feasibility of a study to measure the effect of resisted band antirotation exercises with the use of a double-pulse (DP) breathing METHODS: Ten participants between 20 and 30 years...

Cite
Dagher G, Papuga MO. Assessment of Resisted Trunk Rotation Exercise With and Without . J Chiropr Med. 2019;17(4):244-255doi: 10.1016/j.jcm.2018.07.001.
Dagher, G., & Papuga, M. O. (2018). Assessment of Resisted Trunk Rotation Exercise With and Without . Journal of chiropractic medicine, 17(4), 244-255. https://doi.org/10.1016/j.jcm.2018.07.001
Dagher, Georges, and Papuga, Mark Owen. "Assessment of Resisted Trunk Rotation Exercise With and Without ." Journal of chiropractic medicine vol. 17,4 (2018): 244-255. doi: https://doi.org/10.1016/j.jcm.2018.07.001
Dagher G, Papuga MO. Assessment of Resisted Trunk Rotation Exercise With and Without . J Chiropr Med. 2018 Dec;17(4):244-255. doi: 10.1016/j.jcm.2018.07.001. Epub 2019 Jan 20. PMID: 30846917; PMCID: PMC6391227.
Copy Download .nbib Format: NLM
Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure.

Patient related outcome measures

Robson JC, Dawson J, Cronholm PF, Milman N, Kellom KS, Ashdown S, Easley E, Farrar JT, Gebhart D, Lanier G, McAlear CA, Peck J, Luqmani RA, Shea JA, Tomasson G, Merkel PA.
PMID: 29379322
Patient Relat Outcome Meas. 2018 Jan 04;9:17-34. doi: 10.2147/PROM.S144992. eCollection 2018.

OBJECTIVE: The antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAVs) are multisystem diseases of the small blood vessels. Patients experience irreversible damage and psychological effects from AAV and its treatment. An international collaboration was created to investigate the impact of AAV...

Cite
Robson JC, Dawson J, Cronholm PF, et al. Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure. Patient Relat Outcome Meas. 2018;9:17-34doi: 10.2147/PROM.S144992.
Robson, J. C., Dawson, J., Cronholm, P. F., Milman, N., Kellom, K. S., Ashdown, S., Easley, E., Farrar, J. T., Gebhart, D., Lanier, G., McAlear, C. A., Peck, J., Luqmani, R. A., Shea, J. A., Tomasson, G., & Merkel, P. A. (2018). Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure. Patient related outcome measures, 917-34. https://doi.org/10.2147/PROM.S144992
Robson, Joanna C, et al. "Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure." Patient related outcome measures vol. 9 (2018): 17-34. doi: https://doi.org/10.2147/PROM.S144992
Robson JC, Dawson J, Cronholm PF, Milman N, Kellom KS, Ashdown S, Easley E, Farrar JT, Gebhart D, Lanier G, McAlear CA, Peck J, Luqmani RA, Shea JA, Tomasson G, Merkel PA. Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure. Patient Relat Outcome Meas. 2018 Jan 04;9:17-34. doi: 10.2147/PROM.S144992. eCollection 2018. PMID: 29379322; PMCID: PMC5759851.
Copy Download .nbib Format: NLM
Ensuring the Safety and Security of Frozen Lung Cancer Tissue Collections through the Encapsulation of Dried DNA.

Cancers

Washetine K, Kara-Borni M, Heeke S, Bonnetaud C, Félix JM, Ribeyre L, Bence C, Ilié M, Bordone O, Pedro M, Maitre P, Tanga V, Gormally E, Mossuz P, Lorimier P, Marquette CH, Mouroux J, Cohen C, Lassalle S, Long-Mira E, Clément B, Dagher G, Hofman V, Hofman P.
PMID: 29891792
Cancers (Basel). 2018 Jun 11;10(6). doi: 10.3390/cancers10060195.

Collected specimens for research purposes may or may not be made available depending on their scarcity and/or on the project needs. Their protection against degradation or in the event of an incident is pivotal. Duplication and storage on a...

Cite
Washetine K, Kara-Borni M, Heeke S, et al. Ensuring the Safety and Security of Frozen Lung Cancer Tissue Collections through the Encapsulation of Dried DNA. Cancers (Basel). 2018;10(6)doi: 10.3390/cancers10060195.
Washetine, K., Kara-Borni, M., Heeke, S., Bonnetaud, C., Félix, J. M., Ribeyre, L., Bence, C., Ilié, M., Bordone, O., Pedro, M., Maitre, P., Tanga, V., Gormally, E., Mossuz, P., Lorimier, P., Marquette, C. H., Mouroux, J., Cohen, C., Lassalle, S., Long-Mira, E., Clément, B., Dagher, G., Hofman, V., & Hofman, P. (2018). Ensuring the Safety and Security of Frozen Lung Cancer Tissue Collections through the Encapsulation of Dried DNA. Cancers, 10(6), . https://doi.org/10.3390/cancers10060195
Washetine, Kevin, et al. "Ensuring the Safety and Security of Frozen Lung Cancer Tissue Collections through the Encapsulation of Dried DNA." Cancers vol. 10,6 (2018). doi: https://doi.org/10.3390/cancers10060195
Washetine K, Kara-Borni M, Heeke S, Bonnetaud C, Félix JM, Ribeyre L, Bence C, Ilié M, Bordone O, Pedro M, Maitre P, Tanga V, Gormally E, Mossuz P, Lorimier P, Marquette CH, Mouroux J, Cohen C, Lassalle S, Long-Mira E, Clément B, Dagher G, Hofman V, Hofman P. Ensuring the Safety and Security of Frozen Lung Cancer Tissue Collections through the Encapsulation of Dried DNA. Cancers (Basel). 2018 Jun 11;10(6). doi: 10.3390/cancers10060195. PMID: 29891792; PMCID: PMC6025404.
Copy Download .nbib Format: NLM
The over-35s: early intervention in psychosis services entering uncharted territory.

BJPsych bulletin

Clay F, Allan S, Lai S, Laverty S, Jagger G, Treise C, Perez J.
PMID: 29792245
BJPsych Bull. 2018 Aug;42(4):137-140. doi: 10.1192/bjb.2018.28. Epub 2018 May 24.

Aims and methodFollowing the introduction of new standards for early intervention in psychosis (EIP) in England, EIP services are accepting referrals for people aged 35-65. The Cambridgeshire and Peterborough EIP service (CAMEO) aimed to explore the immediate implications for...

Cite
Clay F, Allan S, Lai S, et al. The over-35s: early intervention in psychosis services entering uncharted territory. BJPsych Bull. 2018;42(4):137-140doi: 10.1192/bjb.2018.28.
Clay, F., Allan, S., Lai, S., Laverty, S., Jagger, G., Treise, C., & Perez, J. (2018). The over-35s: early intervention in psychosis services entering uncharted territory. BJPsych bulletin, 42(4), 137-140. https://doi.org/10.1192/bjb.2018.28
Clay, Felix, et al. "The over-35s: early intervention in psychosis services entering uncharted territory." BJPsych bulletin vol. 42,4 (2018): 137-140. doi: https://doi.org/10.1192/bjb.2018.28
Clay F, Allan S, Lai S, Laverty S, Jagger G, Treise C, Perez J. The over-35s: early intervention in psychosis services entering uncharted territory. BJPsych Bull. 2018 Aug;42(4):137-140. doi: 10.1192/bjb.2018.28. Epub 2018 May 24. PMID: 29792245; PMCID: PMC6436053.
Copy Download .nbib Format: NLM
[No title available]

New microbes and new infections

Tidjani Alou M, Rathored J, Lagier JC, Khelaifia S, Michelle C, Sokhna C, Diallo A, Diallo AB, Fournier PE, Raoult D, Edouard S.
PMID: 28053703
New Microbes New Infect. 2016 Nov 17;15:49-60. doi: 10.1016/j.nmni.2016.11.003. eCollection 2017 Jan.

No abstract available.

Cite
Tidjani Alou M, Rathored J, Lagier JC, et al. . New Microbes New Infect. 2016;15:49-60doi: 10.1016/j.nmni.2016.11.003.
Tidjani Alou, M., Rathored, J., Lagier, J. C., Khelaifia, S., Michelle, C., Sokhna, C., Diallo, A., Diallo, A. B., Fournier, P. E., Raoult, D., & Edouard, S. (2017). . New microbes and new infections, 1549-60. https://doi.org/10.1016/j.nmni.2016.11.003
Tidjani Alou, M, et al. "." New microbes and new infections vol. 15 (2017): 49-60. doi: https://doi.org/10.1016/j.nmni.2016.11.003
Tidjani Alou M, Rathored J, Lagier JC, Khelaifia S, Michelle C, Sokhna C, Diallo A, Diallo AB, Fournier PE, Raoult D, Edouard S. . New Microbes New Infect. 2016 Nov 17;15:49-60. doi: 10.1016/j.nmni.2016.11.003. eCollection 2017 Jan. PMID: 28053703; PMCID: PMC5198730.
Copy Download .nbib Format: NLM
Fluorescence .

Frontiers in medicine

Braubach P, Lippmann T, Raoult D, Lagier JC, Anagnostopoulos I, Zender S, Länger FP, Kreipe HH, Kühnel MP, Jonigk D.
PMID: 28691008
Front Med (Lausanne). 2017 Jun 22;4:87. doi: 10.3389/fmed.2017.00087. eCollection 2017.

Whipple's disease (WD) is a rare chronic systemic infection with a wide range of clinical symptoms, routinely diagnosed in biopsies from the small intestine and other tissues by periodic acid-Schiff (PAS) diastase staining and immunohistological analysis with specific antibodies....

Cite
Braubach P, Lippmann T, Raoult D, et al. Fluorescence . Front Med (Lausanne). 2017;4:87doi: 10.3389/fmed.2017.00087.
Braubach, P., Lippmann, T., Raoult, D., Lagier, J. C., Anagnostopoulos, I., Zender, S., Länger, F. P., Kreipe, H. H., Kühnel, M. P., & Jonigk, D. (2017). Fluorescence . Frontiers in medicine, 487. https://doi.org/10.3389/fmed.2017.00087
Braubach, Peter, et al. "Fluorescence ." Frontiers in medicine vol. 4 (2017): 87. doi: https://doi.org/10.3389/fmed.2017.00087
Braubach P, Lippmann T, Raoult D, Lagier JC, Anagnostopoulos I, Zender S, Länger FP, Kreipe HH, Kühnel MP, Jonigk D. Fluorescence . Front Med (Lausanne). 2017 Jun 22;4:87. doi: 10.3389/fmed.2017.00087. eCollection 2017. PMID: 28691008; PMCID: PMC5479881.
Copy Download .nbib Format: NLM
The Role of Activator Protein-1 (AP-1) Family Members in CD30-Positive Lymphomas.

Cancers

Garces de Los Fayos Alonso I, Liang HC, Turner SD, Lagger S, Merkel O, Kenner L.
PMID: 29597249
Cancers (Basel). 2018 Mar 28;10(4). doi: 10.3390/cancers10040093.

The Activator Protein-1 (AP-1) transcription factor (TF) family, composed of a variety of members including c-JUN, c-FOS and ATF, is involved in mediating many biological processes such as proliferation, differentiation and cell death. Since their discovery, the role of...

Cite
Garces de Los Fayos Alonso I, Liang HC, Turner SD, et al. The Role of Activator Protein-1 (AP-1) Family Members in CD30-Positive Lymphomas. Cancers (Basel). 2018;10(4)doi: 10.3390/cancers10040093.
Garces de Los Fayos Alonso, I., Liang, H. C., Turner, S. D., Lagger, S., Merkel, O., & Kenner, L. (2018). The Role of Activator Protein-1 (AP-1) Family Members in CD30-Positive Lymphomas. Cancers, 10(4), . https://doi.org/10.3390/cancers10040093
Garces de Los Fayos Alonso, Ines, et al. "The Role of Activator Protein-1 (AP-1) Family Members in CD30-Positive Lymphomas." Cancers vol. 10,4 (2018). doi: https://doi.org/10.3390/cancers10040093
Garces de Los Fayos Alonso I, Liang HC, Turner SD, Lagger S, Merkel O, Kenner L. The Role of Activator Protein-1 (AP-1) Family Members in CD30-Positive Lymphomas. Cancers (Basel). 2018 Mar 28;10(4). doi: 10.3390/cancers10040093. PMID: 29597249; PMCID: PMC5923348.
Copy Download .nbib Format: NLM
'.

New microbes and new infections

Ndongo S, Andrieu C, Fournier PE, Lagier JC, Raoult D.
PMID: 28507764
New Microbes New Infect. 2017 Feb 04;18:24-27. doi: 10.1016/j.nmni.2017.01.013. eCollection 2017 Jul.

We report the main characteristics of '

Cite
Ndongo S, Andrieu C, Fournier PE, et al. '. New Microbes New Infect. 2017;18:24-27doi: 10.1016/j.nmni.2017.01.013.
Ndongo, S., Andrieu, C., Fournier, P. E., Lagier, J. C., & Raoult, D. (2017). '. New microbes and new infections, 1824-27. https://doi.org/10.1016/j.nmni.2017.01.013
Ndongo, S, et al. "'." New microbes and new infections vol. 18 (2017): 24-27. doi: https://doi.org/10.1016/j.nmni.2017.01.013
Ndongo S, Andrieu C, Fournier PE, Lagier JC, Raoult D. '. New Microbes New Infect. 2017 Feb 04;18:24-27. doi: 10.1016/j.nmni.2017.01.013. eCollection 2017 Jul. PMID: 28507764; PMCID: PMC5423319.
Copy Download .nbib Format: NLM
[No title available]

New microbes and new infections

Guilhot E, Lagier JC, Raoult D, Khelaifia S.
PMID: 28480042
New Microbes New Infect. 2017 Mar 31;18:3-5. doi: 10.1016/j.nmni.2017.03.002. eCollection 2017 Jul.

Here we report the main characteristics of

Cite
Guilhot E, Lagier JC, Raoult D, et al. . New Microbes New Infect. 2017;18:3-5doi: 10.1016/j.nmni.2017.03.002.
Guilhot, E., Lagier, J. C., Raoult, D., & Khelaifia, S. (2017). . New microbes and new infections, 183-5. https://doi.org/10.1016/j.nmni.2017.03.002
Guilhot, E, et al. "." New microbes and new infections vol. 18 (2017): 3-5. doi: https://doi.org/10.1016/j.nmni.2017.03.002
Guilhot E, Lagier JC, Raoult D, Khelaifia S. . New Microbes New Infect. 2017 Mar 31;18:3-5. doi: 10.1016/j.nmni.2017.03.002. eCollection 2017 Jul. PMID: 28480042; PMCID: PMC5406518.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 364 entries